Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination Treatment

CONCLUSION: These findings reveal a need to further improve T-cell priming and to further make T-cells recognize tumor antigens in uHCC.PMID:38402871 | DOI:10.1159/000537965

Source: Oncology - February 25, 2024 Category: Cancer & Oncology Authors: Hidenari Nagai Takanori Mukozu Teppei Matsui Kunihide Mohri Hideki Nagumo Naoyuki Yoshimine Kojiro Kobayashi Yu Ogino Yasuko Daido Noritaka Wakui Koichi Momiyama Takahisa Matsuda Yoshinori Igarashi Koji Higai Source Type: research